pharmaceuticals

4 bid-rigging cases for supplies of medicinal drug and medical products are consolidated
21 entities and the Office of the Head of the Republic of Khakassia are brought in as respondents to the bid-rigging cases for supplies of medicinal drugs and medical products
more
FAS: the health system is not ready for the risk-sharing drug supply systems
The national health care system requires drastic changes in terms of clinical recommendations, interactions between medical doctors and pharmaceutical companies as well as creating a uniform system of implementing and objective evaluation of the efficiency of medicinal drugs under a risk-sharing model
more
Sergey Puzyrevskiy: patents should not be used to restrict competition
Excessive protection of intellectual rights is not always an incentive for developing innovations and attracting investments
more
FAS: the support system for Russian pharmaceutical companies should not be build up on restricting the number of bidders
Russian pharmaceutical manufacturers should be supported through reducing administrative costs and developing export
more
Timophey Nizhegorodtsev: drug substitutability help prevent bid-rigging
Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev reviewed large-scale changes in the pharmaceutical sector in the past ten years
more